Zentiva Honored with ESG Transparency Award 2025 for Sustainability Efforts
On November 28, 2025, Zentiva, a leading generics pharmaceutical company in Europe, celebrated a momentous achievement by receiving the highly esteemed ESG Transparency Award 2025. This distinguished award, presented by the EUPD Group during the ESG Summit 2025, recognizes organizations that excel in transparency and structure in their Environmental, Social, and Governance (ESG) reporting.
Zentiva's recognition at the Excellence Level of the ESG Transparency Award signifies its commitment to transparent reporting standards and its ability to effectively convey critical ESG information to stakeholders and the public. The award illustrates the company's dedication to integrating sustainability into its overall business strategy, demonstrating how corporate responsibility can coexist with organizational growth.
The ESG Summit 2025, part of the European Sustainability Week, served as a platform to spotlight organizations that are pioneering sustainability practices within their industries. Zentiva's noteworthy contributions to ESG clarity were highlighted through its well-structured approach to sustainability, which aligns with current European regulatory requirements. This includes comprehensive climate-related disclosures encompassing the use of renewable energy across its production sites, underscoring its dedication to a long-term climate strategy.
In terms of reporting accuracy, Zentiva achieved a remarkable level of transparency by providing a detailed calculation of its indirect carbon footprint. This was conducted with an externally reviewed methodology that reinforces the reliability of its data. Additionally, the organization clearly outlined its governance structures, showcasing the vital role played by its Audit Committee in overseeing sustainability-related initiatives. This collective effort epitomizes Zentiva's aspiration to facilitate positive change for both society and the environment.
Steffen Klink, COO of the EUPD Group, remarked, “Zentiva has set a high bar for transparency in ESG communication, demonstrating accountability by openly discussing key challenges and opportunities in their environmental, social, and governance endeavors. Such commitment to a comprehensive performance strategy, alongside ambitious decarbonization targets, is a benchmark for the pharmaceutical industry.”
In acknowledgment of the award, Ines Windisch, Zentiva’s Head of Corporate Affairs and Sustainability, expressed her pride in this recognition, emphasizing that this award is not merely a testament of compliance, but a pivotal milestone that inspires ongoing commitment to sustainability practices. She remarked, “At Zentiva, we believe in taking small actions that can result in significant impacts. This recognition is a reminder that we must act decisively today to secure a sustainable future for the generations to come.”
With over 5,000 employees dedicated to the mission of providing health and well-being across more than 30 countries, Zentiva remains committed to being a leading force in the generics market. Their extensive operations underline a desire to ensure reliable access to high-quality medicines for over 100 million individuals in Europe and beyond. To learn more about their commitment to sustainability and healthcare, visit www.zentiva.com.
Founded in 2000, the EUPD Group leads the charge in assisting organizations to navigate the realms of sustainability with a focus on developing integrated solutions. By applying market research and tailored consulting services across energy, social, and ESG sectors, the EUPD Group aims to build competitive advantages for businesses while fostering sustainable practices in the market. Their ESG Transparency Award was developed to objectively evaluate and honor organizations that successfully establish transparent and effective sustainability reporting.
For more information, visit www.esg-transparency-award.de/en/